Skip to main content
. 2024 Dec 27;11(1):e41519. doi: 10.1016/j.heliyon.2024.e41519

Table 5.

Association analysis of Pri-mir-30c rs928508 SNP with GI cancers.

Cancer Site Model OR 95 % CI p Value ORa 95 % CI pa Value ORb 95 % CI pb Value
GIC Dominant 0.69 0.45–1.06 0.90 0.68 0.44–1.06 0.095 0.64 0.41–0.99 0.048
Recessive 1.04 0.63–1.71 0.880 1 0.59–1.68 0.999 1.04 0.62–1.74 0.881
GG Vs AG 0.67 0.43–1.05 0.082 0.65 0.41–1.06 0.082 0.62 0.38–0.98 0.045
GG Vs AA 0.75 0.43–1.33 0.327 0.76 0.41–1.39 0.375 0.71 0.39–1.28 0.255
G Vs A 0.84 0.64–1.11 0.229 0.85 0.63–1.14 0.272 0.82 0.61–1.08 0.166
GC Dominant 0.49 0.26–0.91 0.024 0.51 0.25–1.01 0.052 0.47 0.25–0.88 0.019
Recessive 1.12 0.58–2.15 0.738 1.02 0.49–2.10 0.955 1.15 0.59–2.24 0.683
GG Vs AG 0.47 0.24–0.85 0.022 0.48 0.23–0.99 0.046 0.45 0.23–0.88 0.019
GG Vs AA 0.54 0.25–1.21 0.133 0.58 0.24–1.43 0.237 0.5 0.22–1.14 0.100
G Vs A 0.84 0.64–1.11 0.229 0.85 0.63–1.14 0.272 0.82 0.61–1.09 0.166
CRC Dominant 0.80 0.46–1.39 0.424 0.77 0.43–1.37 0.372 0.76 0.43–1.36 0.358
Recessive 0.83 0.41–1.65 0.591 0.82 0.40–1.67 0.586 0.79 0.39–1.61 0.515
GG Vs AG 0.73 0.41–1.32 0.302 0.71 0.38–1.29 0.259 0.7 0.38–1.28 0.247
GG Vs AA 1.00 0.46–2.19 0.996 0.99 0.43–2.25 0.974 1 0.45–2.23 0.998
G Vs A 0.96 0.66–1.38 0.808 0.94 0.64–1.38 0.761 0.95 0.65–1.39 0.795
EC Dominant 1.19 0.49–2.90 0.695 1.21 0.49–2.95 0.680 0.92 0.36–2.35 0.856
Recessive 2.27 0.90–5.75 0.083 2.24 0.87–5.75 0.093 2.73 1.02–7.26 0.045
GG Vs AG 1.97 0.67–5.8 0.217 1.99 0.67–5.91 0.216 1.53 0.49–4.84 0.467
GG Vs AA 0.61 0.22–1.71 0.349 0.65 0.23–1.88 0.429 0.48 0.16–1.42 0.183
G Vs A 0.79 0.43–1.46 0.45 0.799 0.43–1.48 0.476 0.65 0.34–1.24 0.191
Others Dominant 0.66 0.23–1.92 0.448 0.74 0.25–2.16 0.582 0.59 0.20–1.80 0.356
Recessive 0.50 0.11–2.26 0.370 0.45 0.09–2.05 0.302 0.54 0.12–2.54 0.439
GG Vs AG 0.55 0.18–1.63 0.278 0.59 0.19–1.78 0.353 0.49 0.15–1.52 0.215
GG Vs AA 1.36 0.25–7.33 0.723 1.48 0.27–8.21 0.655 0.77 0.12–5.35 0.786
G Vs A 1.00 0.51–1.95 0.990 1.1 0.55–2.14 0.818 0.93 0.45–1.89 0.830

CI; Class Interval, OR; Crude Odds Ratio, ORa, Pa; adjusted for age and sex, ORb, Pb; adjusted for Diabetes, diet and region, p values-significant values are bold. GIC; Gastrointestinal cancers, GC; Gastric cancer, CRC; Colorectal cancer, EC; Esophageal cancer.